Aaron Sato | Chief Scientific Officer of Twist Biopharma
Twist Bioscience

Aaron Sato, Chief Scientific Officer of Twist Biopharma, Twist Bioscience

Aaron is CSO of Twist Bioscience and leads the Twist Biopharma business unit.  Prior to Twist, he served as Chief Scientific Officer of LakePharma, leading the California Antibody Center, which discovers novel antibody therapeutics for its clients. He also oversaw all discovery research functions both as Vice President of Protein Sciences at Surrozen, and previously, as Vice President of Research at Sutro Biopharma, Inc. He also held director level positions at both Oncomed and Dyax Corp.


Festival of Biologics Day 2 @ 12:20

Writing the Future of Biologics with an Integrated Offering of Immunization, Libraries, and Machine Learning

Twist Biopharma, a division of twist Bioscience, combines HT DNA synthesis technology with expertise in antibody engineering to provide end-to-end antibody discovery solutions — from gene synthesis to antibody optimization. The result is a make-test cycle that yields better antibodies against challenging targets from immunization, libraries, and machine learning. Twist Biopharma will continue to optimize and expand its discovery, library synthesis and screening capabilities in partnership with others to further utilize their make-test cycle. 

last published: 31/Jan/23 09:55 GMT
last published: 31/Jan/23 09:55 GMT

back to speakers